 of all but one periprocedural lesion and only one
new minor lesion in relation to the 48-hour scan.402 In
contrast, in patients at high risk for CEA, data from the
SCAFFOLD trial showed a low risk of major adverse
events at 30 days as well as a low risk of ipsilateral stroke
from 31 days to 1 year with the Gore carotid stent (W. L.
Gore &